Articles

Breaking news from Day 1 of ESCRS

Hoya Surgical Products now has, what it claims to be, the Sharpest Edge on the market. The yellow aspheric blue-light filter IOLS iSymm has undergone a unique manufacturing process which makes it the sharpest of all commercially available IOLs currently in the market.

Interim results from a Phase II study by Gene Signal suggest that antisense oligonucleotide GS-101 is safe and effective at inhibiting abnormal corneal new blood vessel growth.

The first European Master's degree in Clinical and Surgical Ophthalmology, a prestigious international project of advanced studies for ophthalmological professionals, was presented in Lugano (Switzerland) by the European School for Advanced Studies in Ophthalmology.

$400 million in cash has secured the acquisition of Visiogen for Abbott and secured the latter a next-generation accommodating IOL technology to help presbyopia in cataract patients.

A new study conducted by researchers at the University of Aberdeen, Scotland, has found that the brain predicts the consequences of eye movement even before the eyes take in a new scene.

The pathology of glaucoma is likely to be related to the presence and levels of selenium, according to the results of a study published in the August issue of the British Journal of Ophthalmology.

High levels of the enzyme arginase contributes to vascular eye damage, and therapies to lower its levels could halt progression of diabetic retinopathy (DR), according to researchers at the Medical College of Georgia (MCG) School of Medicine, USA.

Iridex has commenced shipment of its IQ 577 laser systems which is designed to treat vision-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma.

In a head-to-head comparison of six OCT devices, the Spectralis spectral domain OCT (Heidelberg Engineering) showed the lowest co-efficient of variation in a test-retest study.

A new technique of intraductal meibomian gland probing using disposable cannulas of various lengths appears highly effective in providing quick and lasting relief from inflammatory sysmptoms of obstructive meibomian gland disease.

Patients share their postoperative experiences and the dramatic changes in their lives bought about by undergoing refractive lens surgery. Patients had either high myopia, hyperopia and/or severe astigmatism and each received the AT.LISA 366D, a one-piece, 4 haptic multifocal IOL and each has found a new lease of life.

Before and after cataract surgery

Application of genetic knowledge holds huge potential for the future and some believe that it has potential to become larger than the pharmaceutical market. Here Dr Alward examines what it has offered for the understanding and future treatment of glaucoma. Until recently, breakthroughs in glaucoma genetics emerged from painstaking family research, with the discovery of LOXL1 being the exception.

A question and answer session with a canaloplasty expert.

Evaluation of a new value-based treatment approach for wet AMD.

Are the years of research and advocacy at last reaping rewards?

An oil-in-water and a corticosteroid were both effective in eliminating the signs and symptoms of lid wiper epitheliopathy after a 1-month active treatment phase in a recent study. Improvement was effectively maintained with the emollient eye drops in all patients over a 12-month period.

Leadership and evidence-based approaches to alleviate the burden of blindness

The Seeing is Believing initiative at Stardard Chartered Bank

The background to the Egyptian Menia study

World Sight Day is an international day of awareness to focus attention on the global issue of avoidable blindness and visual impairment. This year the theme is Gender and Eye Health – equal access to care

The use of hydroxypropyl cellulose can significantly improve the symptoms of dry eye, resulting in increased quality of life.

A recent study showed that moderate to sever dry eye disease can be best treated with anti-inflammatory medications such as topical cyclosporine. According to one ophthalmologist, cyclosporine can significantly limit progression of dry eye disease and should be considered a 'go-to' therapy for this patient population.

An interview with Dr Mark Tomalla about his experience with the Crystalens HD IOL.

Whilst VISION 2020 is a global initiative it always had a focus on Europe too

Drs Belin and Ambrosio's Enhanced Ectasia module is a keratoconus index, based on pachy

Professor Auffarth of Heidelberg University Eye Clinic reports on the results of his implantation of the LENTIS Mplus and explains how the lens works using a new unique optical principle.

Changes of culture and strategy at Pfizer are good news for ophthalmology

A comparison of an older nanoliter osometer and a newer osometer shows that both devices are effective in measuring tear osmolarity and produce comparable measurements.